Thursday, January 28, 2021
This common drug could cut COVID-19 death risk by nearly 50%, US study shows
This common drug could cut COVID-19 death risk by nearly 50%, US study shows: In a recent study published in Clinical Infectious Diseases, researchers found critically ill COVID-19 patients who received a single dose of the drug Tocilizumab were 45% less likely to die overall. In addition, these patients were more likely to be out of the hospital or off a ventilator one month after treatment. Tocilizumab is originally […]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment